Nicholas J. Silvestri, MD, FAAN

Articles

Use of AChEI and Immunosuppressives in Managing Symptoms

June 20, 2022

James F. Howard Jr., MD and Nicholas J. Silvestri MD, FAAN, share insights regarding acetylcholinesterase inhibitors and immunosuppressive therapy as first-line treatments for patients with myasthenia gravis.